Navigation Links
Provonix Joins the Medrio Partner Program
Date:5/8/2013

San Francisco, CA and Mullica Hill, NJ (PRWEB) May 08, 2013

Provonix, a customer-focused CRO providing innovative clinical trial solutions for pharmaceutical, biotechnology, and medical device companies, today joined the Medrio Partner Program after earning accreditation in Medrio’s eClinical Software as a Software (SaaS) platform. The Medrio Partner Program is a collaborative effort aligning Medrio resources with trusted contract research organizations (CROs) and consultancies to deliver superior customer experiences in clinical research.

“Provonix is very excited to be part of Medrio’s Partner Program,” said Jeff Botbyl, Founder and CEO of Provonix. “Combining our expertise in clinical research with Medrio’s innovative eClinical software solution will bring great value to our clients. Delivering exceptional services is a win for both companies.”

Medrio’s Partner Program offers financial incentives, comprehensive partner training, extensive sales and marketing support, and deep product insight to all partners.

“Medrio is pleased to welcome Provonix to our Partner Program. We look forward to working closely with Provonix to continue to scale our documented excellence in customer experience,” says Scott Weidley, Director of Sales & Marketing for Medrio.

About Medrio, Inc.

Medrio offers an integrated eClinical Software as a Service (SaaS) platform with a fully hosted Electronic Data Capture (EDC) system that drastically reduces study timelines and costs by putting study managers in control of their studies. By enabling studies to be built completely online without the need for any custom development, Medrio eClinical software allows studies to be ready in days instead of weeks. Medrio has been used successfully in Phase I-IV trials, registries, and other clinical studies by a number of leading contract research organizations (CROs), as well as biopharmaceutical and device companies. Founded in 2005, Medrio is headquartered in the San Francisco Bay Area. For more information visit http://www.medrio.com.

About Provonix, LLC

Provonix is a specialized contract research organization providing exceptional support in: Biostatistics, Statistical Programming, Data Management, Medical Writing and Pharmacokinetic Analysis. Provonix is a client-focused CRO of highly experienced professionals with a commitment and responsiveness to customers, and a shared goal in developing products that will help people lead better, healthier lives. For more information visit: http://www.provonix.com.

Read the full story at http://www.prweb.com/releases/eclinicalsoftware/medrio/prweb10706761.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Michael Cusumano, MITs Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors
2. Robert Farrell Joins Bionovos Board of Directors
3. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
4. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
5. First Choice Rehabilitation Specialists Joins Select Medical
6. Excel Life Sciences Joins DATATRAKs Connect Partner Program
7. Marina Biotech, Inc. Joins OTCQX
8. Richard H. Scheuermann, Ph.D. Joins J. Craig Venter Institute as Director of Informatics
9. Dr. David L. Blecker MD, MPH, F.A.C.P. Joins Inergetics Advisory Board to Co-Develop and Market Products to Penetrate Nephrology Market
10. QIAGEN Joins Grand Challenges in Global Health Initiative to Bring Advanced Point-of-Care Diagnostics to Worlds Poorest Countries
11. Cancer Immunotherapy Expert Joins Pacific Meso Center Research Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... OF PRUSSIA, PA (PRWEB) , ... January 18, ... ... disrupt clinical operations again at the CHI SCOPE Summit for Clinical Ops Executives ... AstraZeneca in engaging panel discussions to examine vital clinical research issues such as ...
(Date:1/18/2017)... , Jan. 18, 2017 Shareholder rights law ... into whether the board members of CoLucid Pharmaceuticals, Inc. ... in connection with the proposed sale of the Company ... company that develops small molecules for the acute treatment ... announced it had signed a definitive merger agreement with ...
(Date:1/18/2017)... India , Jan. 18, 2017  Market Research Future published ... Diagnostics Market is expected to grow at a CAGR of 12% ... ... disease caused due to the abnormal cell division without any control. ... cause harm to them. These cancer cells can spread to other ...
(Date:1/17/2017)... 2017  An international team of researchers from ... Boniface Hospital Albrechtsen Research Centre/University of Manitoba have ... health need affecting nearly one in 15 Americans. ... their results identify small molecule drugs with neuroprotective ... injury in animal models of metabolic, chemical and ...
Breaking Biology Technology:
(Date:12/15/2016)... , Dec. 14, 2016 "Increase in ... biometrics market" The mobile biometrics market is expected to ... 49.33 billion by 2022, at a CAGR of 29.3% ... factors such as the growing demand for smart devices, ... transactions. "Software component is expected to grow ...
(Date:12/8/2016)... India , Dec. 8, 2016 Market Research Future ... Service Market. The global Mobile Biometric Security and Service Market is ... 2016 to 2022. Market Highlights: ... , , Mobile ... pace due to the increasing need of authentication and security from ...
(Date:12/7/2016)... December 7, 2016 According to a new market research ... Tool (Facial Expression, Voice Recognition), Service, Application Area, End User, And Region - ... grow from USD 6.72 Billion in 2016 to USD 36.07 Billion by 2021, ... Continue Reading ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):